Newfeed

SUZHOU, China and ROCKVILLE, Md., Dec. 13, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a randomiz

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: